| Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis SB Roberts, GM Hirschfield, LJ Worobetz, C Vincent, JA Flemming, ... Hepatology 76 (2), 303-316, 2022 | 9 | 2022 |
| Real world effectiveness of obeticholic acid in patients with primary biliary cholangitis: The global experience A Gulamhusein, SB Roberts, N Haliday, M Carbone, D D'Amato, ... The Liver Meeting Digital Experience™, 2020 | 2 | 2020 |
| Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis SB Roberts, WJ Choi, L Worobetz, C Vincent, JA Flemming, A Cheung, ... JHEP reports, 101168, 2024 | | 2024 |
| Mo1581 THE NEUTROPHIL-LYMPHOCYTE RATIO ENHANCES LIVER-TRANSPLANTFREE SURVIVAL PREDICTION BEYOND CONVENTIONAL METRICS; A MACHINE LEARNING STUDY K Bashiri, B Aziz, H Syed, SB Roberts, L Worobetz, J Hercun, E Lytvyak, ... Gastroenterology 166 (5), S-1701, 2024 | | 2024 |
| ROLE OF NON-INVASIVE MARKERS IN ASSESSING THE DEGREE OF FIBROSIS IN AUTOIMMUNE HEPATITIS, PRIMARY BILIARY CHOLANGITIS, AND OVERLAP SYNDROME A CANADIAN MULTI-CENTER REVIEW M Alsager, SB Roberts, S Son, A Teriaky, N Selzner, M Cameron, ... HEPATOLOGY 78, S2021-S2023, 2023 | | 2023 |
| Loss of innate and adaptive effector lymphocytes is associated with diminished globe score prognosis in patients with primary biliary cholangitis H Syed, G Vallée, B Aziz, N Sun, M Osman, E Lytvyak, HHI Ko, MG Swain, ... Journal of Hepatology 78, S426-S427, 2023 | | 2023 |
| Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation B Aziz, B Kok, M Cheah, E Lytvyak, C Moctezuma-Velazquez, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | | 2022 |
| ASSOCIATIONS BETWEEN ETHNICITY, BIOCHEMICAL DISEASE SEVERITY, AND LIVER TRANSPLANT-FREE SURVIVAL IN CANADIAN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS SB Roberts, L Worobetz, C Vincent, JA Flemming, C Tsien, KM Qumosani, ... HEPATOLOGY 74, 73A-74A, 2021 | | 2021 |
| ELEVATED NEUTROPHIL/LYMPHOCYTE RATIO (NLR) ONE-YEAR POST-UDCA IS ASSOCIATED WITH DECREASED LIVER TRANSPLANT-FREE AND OVERALL SURVIVAL IN PBC B Aziz, H Syed, SB Roberts, S Faheem, E Lytvyak, J Koo, L Worobetz, ... HEPATOLOGY 74, 763A-764A, 2021 | | 2021 |
| Patterns of biochemical response during long-term UDCA treatment in patients with primary biliary cholangitis: association with liver transplant-free survival S Roberts, L Worobetz, C Vincent, J Flemming, C Tsien, K Qumosani, ... JOURNAL OF HEPATOLOGY 75, S228-S229, 2021 | | 2021 |
| Severe cholestasis during the first year post-transplant predicts primary sclerosing cholangitis recurrence BHG Aziz | | 2021 |
| ELEVATED NEUTROPHIL/LYMPHOCYTE RATIO (NLR) ONE-YEAR POST-DIAGNOSIS IS ASSOCIATED WITH DECREASED LIVER TRANSPLANT-FREE AND OVERALL SURVIVAL IN PBC B Aziz, SB Roberts, E Lytvyak, AJ Montano-Loza, BE Hansen, AL Mason The Liver Meeting Digital Experience™, 2020 | | 2020 |
| QUALITY OF LIFE AMONG PATIENTS WITH PRIMARY BILIARY CHOLANGITIS DURING CANADA’S STATE OF EMERGENCY RESPONSE TO COVID-19 SB Roberts, B Aziz, C Plagiannakos, M Saini, HH Ko, C Tsien, ... The Liver Meeting Digital Experience™, 2020 | | 2020 |
| Self-reported experiences of patients living with primary biliary cholangitis (PBC): Are we treating the liver but not the patient? KP Ismond, B Aziz, GM Wright, AL Mason Canadian Liver Journal 2 (1), 45-47, 2019 | | 2019 |
Andrew Lawrence MasonUniversity of Alberta在 ualberta.ca 的电子邮件经过验证
